Review



atcc 8459 strain  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC atcc 8459 strain
    Atcc 8459 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 117 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atcc 8459 strain/product/ATCC
    Average 95 stars, based on 117 article reviews
    atcc 8459 strain - by Bioz Stars, 2026-04
    95/100 stars

    Images



    Similar Products

    95
    ATCC atcc 8459 strain
    Atcc 8459 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atcc 8459 strain/product/ATCC
    Average 95 stars, based on 1 article reviews
    atcc 8459 strain - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    95
    ATCC e faecium strain atcc 8459
    Decrease of <t>Enterococcus</t> <t>faecium</t> in moisture enhanced reconstructed ground chicken with 0, 1, 3, and 5 % of salt over time (s) in response to temperature treatments at 62, 66, 70, and 74°C in a circulated thermal water bath.
    E Faecium Strain Atcc 8459, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e faecium strain atcc 8459/product/ATCC
    Average 95 stars, based on 1 article reviews
    e faecium strain atcc 8459 - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    95
    ATCC strains atcc 8459
    Decrease of <t>Enterococcus</t> <t>faecium</t> in moisture enhanced reconstructed ground chicken with 0, 1, 3, and 5 % of salt over time (s) in response to temperature treatments at 62, 66, 70, and 74°C in a circulated thermal water bath.
    Strains Atcc 8459, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/strains atcc 8459/product/ATCC
    Average 95 stars, based on 1 article reviews
    strains atcc 8459 - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    95
    ATCC e faecium atcc 8459 strain
    Decrease of <t>Enterococcus</t> <t>faecium</t> in moisture enhanced reconstructed ground chicken with 0, 1, 3, and 5 % of salt over time (s) in response to temperature treatments at 62, 66, 70, and 74°C in a circulated thermal water bath.
    E Faecium Atcc 8459 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e faecium atcc 8459 strain/product/ATCC
    Average 95 stars, based on 1 article reviews
    e faecium atcc 8459 strain - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    95
    ATCC e faecium strains
    In vitro formation and in vivo presence of the EntF* metabolite. a Sequences of the enterocin induction factor pro-peptide, mature quorum sensing peptide EntF, and its metabolite EntF*. b In vitro formation rate of EntF* from EntF in colon ( n = 7) and feces ( n = 4) homogenates. Bars represent the mean formation rate ± SEM from independent experiments. Statistically significant differences were determined by a Mann-Whitney U test with indicated p -values. c Apparent permeability coefficients ( P app ) of PapRIV, EntF*, and EDF-analog in Caco-2 cells. Bars represent mean P app values ± SEM ( n = 6 independent experiments); the shaded area represents the limit of detection. d Flow chart displaying the experimental design stages, from serum sampling to peptide detection and further confirmation of EntF* presence in vivo. Different LC-MS methods: LC 1 -MS 1 , reversed-phase ultra-high-performance liquid chromatography (RP-UPLC) using triple quadrupole (TQ) in MRM mode; LC 1 -MS 2 , high-resolution quadrupole time-of-flight; LC 1 -MS 3 , high-resolution quadrupole-orbitrap; LC 2 -MS 1 , HILIC-amide UPLC using TQ in MRM mode. qPCR was performed on feces sample of mice from the same set to demonstrate the presence of EntF-encoding DNA sequences from E. <t>faecium</t> . e Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using RP-UPLC with detection by electrospray ionization mass spectrometry (ESI-MS) using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). f Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using HILIC amide UPLC with detection by ESI-MS using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). g Isotopic distribution of the double charged EntF* measured in a positive serum sample using RP-UPLC with detection by ESI-MS using quadrupole-orbitrap. h High-resolution tandem mass spectrum of EntF* with characteristic fragments, using RP-UPLC with detection by Q-TOF. i In vivo presence of EntF* in gnotobiotic mice treated with EntF-producing bacterial strains. Number of EntF DNA copies per gram of feces measured four days after treatment with placebo (300 μL BHI medium) (limit of detection: 10 5 copies/g) (left). EntF* concentration in colon content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (middle). EntF* concentration in serum content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (right)
    E Faecium Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e faecium strains/product/ATCC
    Average 95 stars, based on 1 article reviews
    e faecium strains - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    95
    ATCC reference strain e faecium atcc 8459
    In vitro formation and in vivo presence of the EntF* metabolite. a Sequences of the enterocin induction factor pro-peptide, mature quorum sensing peptide EntF, and its metabolite EntF*. b In vitro formation rate of EntF* from EntF in colon ( n = 7) and feces ( n = 4) homogenates. Bars represent the mean formation rate ± SEM from independent experiments. Statistically significant differences were determined by a Mann-Whitney U test with indicated p -values. c Apparent permeability coefficients ( P app ) of PapRIV, EntF*, and EDF-analog in Caco-2 cells. Bars represent mean P app values ± SEM ( n = 6 independent experiments); the shaded area represents the limit of detection. d Flow chart displaying the experimental design stages, from serum sampling to peptide detection and further confirmation of EntF* presence in vivo. Different LC-MS methods: LC 1 -MS 1 , reversed-phase ultra-high-performance liquid chromatography (RP-UPLC) using triple quadrupole (TQ) in MRM mode; LC 1 -MS 2 , high-resolution quadrupole time-of-flight; LC 1 -MS 3 , high-resolution quadrupole-orbitrap; LC 2 -MS 1 , HILIC-amide UPLC using TQ in MRM mode. qPCR was performed on feces sample of mice from the same set to demonstrate the presence of EntF-encoding DNA sequences from E. <t>faecium</t> . e Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using RP-UPLC with detection by electrospray ionization mass spectrometry (ESI-MS) using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). f Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using HILIC amide UPLC with detection by ESI-MS using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). g Isotopic distribution of the double charged EntF* measured in a positive serum sample using RP-UPLC with detection by ESI-MS using quadrupole-orbitrap. h High-resolution tandem mass spectrum of EntF* with characteristic fragments, using RP-UPLC with detection by Q-TOF. i In vivo presence of EntF* in gnotobiotic mice treated with EntF-producing bacterial strains. Number of EntF DNA copies per gram of feces measured four days after treatment with placebo (300 μL BHI medium) (limit of detection: 10 5 copies/g) (left). EntF* concentration in colon content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (middle). EntF* concentration in serum content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (right)
    Reference Strain E Faecium Atcc 8459, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference strain e faecium atcc 8459/product/ATCC
    Average 95 stars, based on 1 article reviews
    reference strain e faecium atcc 8459 - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    Image Search Results


    Decrease of Enterococcus faecium in moisture enhanced reconstructed ground chicken with 0, 1, 3, and 5 % of salt over time (s) in response to temperature treatments at 62, 66, 70, and 74°C in a circulated thermal water bath.

    Journal: Poultry Science

    Article Title: Applying microbial predictive and machine learning model data to evaluate thermal inactivation of salmonella and the surrogate enterococcus faecium in reconstructed ground chicken meat affected by temperature and salt concentrations

    doi: 10.1016/j.psj.2025.105422

    Figure Lengend Snippet: Decrease of Enterococcus faecium in moisture enhanced reconstructed ground chicken with 0, 1, 3, and 5 % of salt over time (s) in response to temperature treatments at 62, 66, 70, and 74°C in a circulated thermal water bath.

    Article Snippet: Thermal processing studies have shown that a minimum extrusion temperature of 74°C in a balanced carbohydrate-protein meal can achieve a 5-log reduction of E. faecium strain ATCC 8459.

    Techniques:

    Decrease of Enterococcus faecium (Log 10 CFU) in moisture enhanced reconstructed ground chicken with 0, 1, 3, and 5 % of salt over time (s) in response to temperature treatments at 62, 66, 70, and 74°C in a circulated thermal water bath. Lines through data show predicted Log 10 CFU from model that included an orthogonal polynomial of time in sec, NaCl concentrations, and water bath temperatures. Dashed lines show the thermal inactivation threshold for each treatment. Estimated d -values indicated in boxes on each panel.

    Journal: Poultry Science

    Article Title: Applying microbial predictive and machine learning model data to evaluate thermal inactivation of salmonella and the surrogate enterococcus faecium in reconstructed ground chicken meat affected by temperature and salt concentrations

    doi: 10.1016/j.psj.2025.105422

    Figure Lengend Snippet: Decrease of Enterococcus faecium (Log 10 CFU) in moisture enhanced reconstructed ground chicken with 0, 1, 3, and 5 % of salt over time (s) in response to temperature treatments at 62, 66, 70, and 74°C in a circulated thermal water bath. Lines through data show predicted Log 10 CFU from model that included an orthogonal polynomial of time in sec, NaCl concentrations, and water bath temperatures. Dashed lines show the thermal inactivation threshold for each treatment. Estimated d -values indicated in boxes on each panel.

    Article Snippet: Thermal processing studies have shown that a minimum extrusion temperature of 74°C in a balanced carbohydrate-protein meal can achieve a 5-log reduction of E. faecium strain ATCC 8459.

    Techniques:

    In vitro formation and in vivo presence of the EntF* metabolite. a Sequences of the enterocin induction factor pro-peptide, mature quorum sensing peptide EntF, and its metabolite EntF*. b In vitro formation rate of EntF* from EntF in colon ( n = 7) and feces ( n = 4) homogenates. Bars represent the mean formation rate ± SEM from independent experiments. Statistically significant differences were determined by a Mann-Whitney U test with indicated p -values. c Apparent permeability coefficients ( P app ) of PapRIV, EntF*, and EDF-analog in Caco-2 cells. Bars represent mean P app values ± SEM ( n = 6 independent experiments); the shaded area represents the limit of detection. d Flow chart displaying the experimental design stages, from serum sampling to peptide detection and further confirmation of EntF* presence in vivo. Different LC-MS methods: LC 1 -MS 1 , reversed-phase ultra-high-performance liquid chromatography (RP-UPLC) using triple quadrupole (TQ) in MRM mode; LC 1 -MS 2 , high-resolution quadrupole time-of-flight; LC 1 -MS 3 , high-resolution quadrupole-orbitrap; LC 2 -MS 1 , HILIC-amide UPLC using TQ in MRM mode. qPCR was performed on feces sample of mice from the same set to demonstrate the presence of EntF-encoding DNA sequences from E. faecium . e Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using RP-UPLC with detection by electrospray ionization mass spectrometry (ESI-MS) using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). f Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using HILIC amide UPLC with detection by ESI-MS using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). g Isotopic distribution of the double charged EntF* measured in a positive serum sample using RP-UPLC with detection by ESI-MS using quadrupole-orbitrap. h High-resolution tandem mass spectrum of EntF* with characteristic fragments, using RP-UPLC with detection by Q-TOF. i In vivo presence of EntF* in gnotobiotic mice treated with EntF-producing bacterial strains. Number of EntF DNA copies per gram of feces measured four days after treatment with placebo (300 μL BHI medium) (limit of detection: 10 5 copies/g) (left). EntF* concentration in colon content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (middle). EntF* concentration in serum content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (right)

    Journal: BMC Biology

    Article Title: The quorum sensing peptide EntF* promotes colorectal cancer metastasis in mice: a new factor in the host-microbiome interaction

    doi: 10.1186/s12915-022-01317-z

    Figure Lengend Snippet: In vitro formation and in vivo presence of the EntF* metabolite. a Sequences of the enterocin induction factor pro-peptide, mature quorum sensing peptide EntF, and its metabolite EntF*. b In vitro formation rate of EntF* from EntF in colon ( n = 7) and feces ( n = 4) homogenates. Bars represent the mean formation rate ± SEM from independent experiments. Statistically significant differences were determined by a Mann-Whitney U test with indicated p -values. c Apparent permeability coefficients ( P app ) of PapRIV, EntF*, and EDF-analog in Caco-2 cells. Bars represent mean P app values ± SEM ( n = 6 independent experiments); the shaded area represents the limit of detection. d Flow chart displaying the experimental design stages, from serum sampling to peptide detection and further confirmation of EntF* presence in vivo. Different LC-MS methods: LC 1 -MS 1 , reversed-phase ultra-high-performance liquid chromatography (RP-UPLC) using triple quadrupole (TQ) in MRM mode; LC 1 -MS 2 , high-resolution quadrupole time-of-flight; LC 1 -MS 3 , high-resolution quadrupole-orbitrap; LC 2 -MS 1 , HILIC-amide UPLC using TQ in MRM mode. qPCR was performed on feces sample of mice from the same set to demonstrate the presence of EntF-encoding DNA sequences from E. faecium . e Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using RP-UPLC with detection by electrospray ionization mass spectrometry (ESI-MS) using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). f Chromatographic profiles of (1) negative serum sample, (2) positive serum sample, (3) serum sample from EntF*-treated mice. Chromatographic profiles were obtained using HILIC amide UPLC with detection by ESI-MS using TQ in MRM mode ( m/z = 865 ➔ 202.08 + 315.17). g Isotopic distribution of the double charged EntF* measured in a positive serum sample using RP-UPLC with detection by ESI-MS using quadrupole-orbitrap. h High-resolution tandem mass spectrum of EntF* with characteristic fragments, using RP-UPLC with detection by Q-TOF. i In vivo presence of EntF* in gnotobiotic mice treated with EntF-producing bacterial strains. Number of EntF DNA copies per gram of feces measured four days after treatment with placebo (300 μL BHI medium) (limit of detection: 10 5 copies/g) (left). EntF* concentration in colon content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (middle). EntF* concentration in serum content. No EntF* was detected in the placebo group (the red line indicates the limit of detection) (right)

    Article Snippet: At day 0, the placebo group was treated with the cell medium (BHI), the control group received a mixture of 3 EntF-negative E. faecium strains (NCIMB 10415; W54 and LMG S-28935 each 10 8 CFU per strain) suspended in 300 μL of BHI, while the test group received a mixture of 3 EntF-producing E. faecium strains (LMG 23236; T-110 and ATCC 8459 each 10 8 CFU/strain) suspended in 300 μL of BHI.

    Techniques: In Vitro, In Vivo, MANN-WHITNEY, Permeability, Sampling, Liquid Chromatography with Mass Spectroscopy, High Performance Liquid Chromatography, Targeted Proteomics, Hydrophilic Interaction Liquid Chromatography, Mass Spectrometry, Concentration Assay